Outcome of Azacitidine Therapy in Acute Myeloid Leukemia Is not Improved by Concurrent Vorinostat Therapy but Is Predicted by a Diagnostic Molecular Signature. (2017)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/1078-0432.ccr-17-1423
PubMed Identifier: 28765326
Publication URI: http://europepmc.org/abstract/MED/28765326
Type: Journal Article/Review
Volume: 23
Parent Publication: Clinical cancer research : an official journal of the American Association for Cancer Research
Issue: 21
ISSN: 1078-0432